{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:35:03Z","timestamp":1792650903182,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["461080000"],"award-info":[{"award-number":["461080000"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019147","name":"Universit\u00e4tsmedizin G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114751","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T15:42:51Z","timestamp":1630165371000},"page":"114751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter"],"prefix":"10.1016","volume":"192","author":[{"given":"Alexandra","family":"Sachkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alexander","family":"Doetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Brockm\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114751_b0005","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.5453","article-title":"Treatment of attention-deficit\/hyperactivity disorder in adolescents: a systematic Review","volume":"315","author":"Chan","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mcna.2017.08.010","article-title":"Obesity pharmacotherapy","volume":"102","author":"Saunders","year":"2018","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2021.114751_b0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.bcp.2021.114751_b0025","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2021","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.bcp.2021.114751_b0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2016.11.008","article-title":"Classification Systems of Secondary Active Transporters","volume":"38","author":"Perland","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2021.114751_b0035","first-page":"G563","article-title":"Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells, American Journal of Physiology-Gastrointestinal and Liver","volume":"278","author":"Mizuuchi","year":"2000","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/dmd.114.061002","article-title":"Involvement of the H+\/Organic Cation Antiporter in Nicotine Transport in Rat Liver","volume":"43","author":"Tega","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bcp.2021.114751_b0045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/jcbfm.2009.54","article-title":"Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs","volume":"29","author":"Andr\u00e9","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu001","article-title":"Carrier-Mediated Cocaine Transport at the Blood-Brain Barrier as a Putative Mechanism in Addiction Liability","volume":"18","author":"Chapy","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114751_b0055","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1111\/bph.13246","article-title":"A polyspecific drug\/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier","volume":"172","author":"Chapy","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114751_b0060","doi-asserted-by":"crossref","first-page":"112581","DOI":"10.1016\/j.jep.2020.112581","article-title":"A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids","volume":"252","author":"Cong","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2021.114751_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-017-0087-9","article-title":"Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain","volume":"15","author":"Akanuma","year":"2018","journal-title":"Fluids Barriers CNS."},{"issue":"9","key":"10.1016\/j.bcp.2021.114751_b0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acsmedchemlett.8b00099","article-title":"Design Synthesis, and Blood-Brain Barrier Transport Study of Pyrilamine Derivatives as Histone Deacetylase Inhibitors","volume":"9","author":"Hiranaka","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2021.114751_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.609811","article-title":"Cellular Uptake of Psychostimulants \u2013 Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?","volume":"11","author":"Jensen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114751_b0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2017.03.034","article-title":"Pyrilamine-sensitive proton-coupled organic cation (H+\/OC) antiporter for brain-specific drug delivery","volume":"254","author":"Wang","year":"2017","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.bcp.2021.114751_b0085","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1177\/0271678X16662042","article-title":"Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging","volume":"37","author":"Auvity","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"20","key":"10.1016\/j.bcp.2021.114751_b0090","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1111\/bph.13258","article-title":"Pharmacophore-based discovery of inhibitors of a novel drug\/proton antiporter in human brain endothelial hCMEC\/D3 cell line","volume":"172","author":"Chapy","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.bcp.2021.114751_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2008.06.090","article-title":"pH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers","volume":"592","author":"Crowe","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbamem.2007.08.023","article-title":"Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells","volume":"1778","author":"Kuwayama","year":"2008","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.bcp.2021.114751_b0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.113.203257","article-title":"Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter, OCT2","volume":"346","author":"Belzer","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2021.114751_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11095-018-2526-y","article-title":"Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2)","volume":"35","author":"Zhu","year":"2018","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2133\/dmpk.DMPK-13-RG-058","article-title":"Functional Expression of Organic Cation\/carnitine Transporter 2 (OCTN2\/SLC22A5) in Human Brain Capillary Endothelial Cell Line hCMEC\/D3, a Human Blood-brain Barrier Model","volume":"29","author":"Okura","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.bcp.2021.114751_b0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4062\/biomolther.2017.082","article-title":"Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters","volume":"25","author":"Tun","year":"2017","journal-title":"Biomol. Ther. (Seoul)."},{"issue":"15-16","key":"10.1016\/j.bcp.2021.114751_b0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2012.03.015","article-title":"Evidence-based approach to assess passive diffusion and carrier-mediated drug transport","volume":"17","author":"Di","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2021.114751_b0130","series-title":"Transporters in Drug Development: Discovery, Optimization, Clinical Study and Regulation","first-page":"37","article-title":"In Vitro Characterization of Interactions with Drug Transporting Proteins","author":"Artursson","year":"2013"},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-8118-10-8","article-title":"Functional expression of a proton-coupled organic cation (H+\/OC) antiporter in human brain capillary endothelial cell line hCMEC\/D3, a human blood-brain barrier model","volume":"10","author":"Shimomura","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"10.1016\/j.bcp.2021.114751_b0140","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.molpharmaceut.0c01104","article-title":"Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters","volume":"18","author":"Ruan","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2021.114751_b0145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jat\/bky110","article-title":"Postmortem Brain-Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate","volume":"43","author":"Nedahl","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.bcp.2021.114751_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/pharmaceutics12040308","article-title":"An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans","volume":"12","author":"Chaves","year":"2020","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2021.114751_b0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/dmd.116.074708","article-title":"Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters","volume":"45","author":"Wagner","year":"2017","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","article-title":"In Vitro Characterization of Ephedrine-Related Stereoisomers at Biogenic Amine Transporters and the Receptorome Reveals Selective Actions as Norepinephrine Transporter Substrates","volume":"307","author":"Rothman","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114751_b0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.191056","article-title":"Non-classical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators and Partial Substrates","volume":"346","author":"Schmitt","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2021.114751_b0175","doi-asserted-by":"crossref","first-page":"e0136451","DOI":"10.1371\/journal.pone.0136451","article-title":"Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates","volume":"10","author":"Hacker","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2021.114751_b0180","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm."},{"issue":"7","key":"10.1016\/j.bcp.2021.114751_b0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/d41573-020-00056-6","article-title":"The RESOLUTE consortium: unlocking SLC transporters for drug discovery","volume":"19","author":"Superti-Furga","year":"2020","journal-title":"Nat Rev Drug Discov."},{"issue":"3","key":"10.1016\/j.bcp.2021.114751_b0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-017-2392-2","article-title":"No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA","volume":"74","author":"Vizeli","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:36:06Z","timestamp":1757770566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"alternative-id":["S0006295221003671"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114751","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114751"}}